Gelesis Holdings Inc. (GLS) Fundamentals

Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.
SHARE INFORMATION
Market Cap$ 126,041,506
Shares Outstanding72,437,647
Float19,470,730
Percent Float26.88%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 11,185,000
Latest Fiscal EPS$ -2.60
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions49
Institutional Holdings Date2022-06-30
Institutional Bought Previous 3 Months27,488
Institutional Holdings Percent16.9%
Institutional Sold Previous 3 Months10,077
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months5,428,763
Insider Holdings Percent6.3
Insider Sold Previous 3 Months-
Insider Shares Owned4,532,686
TRADING INFO
52 Week High$ 12.23
52 Week Low$ 1.45
52 Week High Change$ -82.21
21 Day Moving Average$ 2.2171
21 Day Extended Moving Average$ 2.2831
50 Day Moving Average$ 3.7686
50 Day Extended Moving Average$ 3.2956
200 Day Moving Average$ 6.5198
200 Day Extended Moving Average$ 5.8769
10 Day Average Volume161,130
20 Day Average Volume196,370
30 Day Average Volume158,692
50 Day Average Volume132,300
Alpha-0.056886
Beta1.9782
Standard Deviation0.208150
R20.218560
7 Day Price Change$ 0.20
7 Day Percent Change12.99%
21 Day Price Change$ -0.10
21 Day Percent Change-5.43%
30 Day Price Change$ -3.24
30 Day Percent Change-65.06%
Month to Date Price Change$ 0.19
Month to Date Percent Change12.26%
Quarter to Date Price Change$ 0.19
Quarter to Date Percent Change12.26%
180 Day Price Change$ -8.24
180 Day Percent Change-82.57%
200 Day Price Change$ -8.19
200 Day Percent Change-82.48%
Year to Date Price Change$ -8.22
Year to Date Percent Change-82.53%

Gelesis Holdings Inc. (GLS) Key Ratios

PROFITABILITY
EBIT Margin-74.1%
EBITDA Margin-53.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin22.6%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 15,598,000
Revenue Per Share$ 0.2153
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book11.30
Total Debt To Equity3.80
Int Coverage-69.70
Current Ratio2.50
Leverage Ratio29.80
Quick Ratio1.70
Long Term Debt To Capital0.78
VALUATION MEASURES
PE Ratio-0.60
Enterprise Value$ 117,623,105
Price to Sales8.0806
Price to Free Cash-1.20
PE High Last 5 Years0.00
Price To Book11.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book11.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.80
Invoice Turnover1.20
Assets Turnover0.20
Return Assets-117.18
Return on Equity-1,784.81
Return on Capital-90.97

Gelesis Holdings Inc. (GLS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEOYishai Zohar
Emplyoees103
Last Audit-
CIK0001805087
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address405 West 14th Street
Austin, TX 78701
Websitehttps://www.gelesis.com
Facsimile-
Telephone+1 512 340-7800
Email-
Your Recent History
NYSE
GLS
Gelesis
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220707 05:31:44